Evidence map›Paper›PMID 42754918›Full record

ArticlePigment cell & melanoma research2026

Polygenic Risk Scores and Its Association With Cutaneous Melanoma Risk in the Swedish Population.

Hildur Helgadottir, Muyi Yang, Ivette Raices Cruz, Karina Schultz, Veronica Höiom

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hildur HelgadottirDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-0735-4771
Muyi YangDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Ivette Raices CruzDivision of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Karina SchultzDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-4086-1289
Veronica HöiomDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-3957-5667

Funding

Cancerfonden 20 0156 FCancerfonden 21 1486 PjCancerfonden 24 3826 PjRadiumhemmets Forskningsfonder 194092Radiumhemmets Forskningsfonder 194103Radiumhemmets Forskningsfonder 2240233Region Stockholm FoUI-1023897Region Stockholm FoUI-975235Stiftelsen Tornspiran
6 · The paper itself

Abstract

Polygenic risk scores can quantify an individual's genetic predisposition by combining the effects of multiple gene variants linked to melanoma susceptibility. Previous studies have demonstrated that PRS is strongly associated with melanoma risk and can improve the identification of high-risk individuals beyond that identified by traditional risk factors. The aim of this study was to calculate PRS for melanoma susceptibility in the Swedish population. Sixty-four single nucleotide polymorphisms, previously associated with melanoma susceptibility, were used to calculate PRS for 599 melanoma patients with or without family history of melanoma and 1180 controls. PRS values were significantly higher among melanoma patients than among controls, with an area under the receiver operating characteristic curve of 0.710. Individuals in the highest PRS decile had a fourfold increased melanoma risk compared with those in the 5th-6th decile. PRS was strongly influenced by the pigmentation-related traits skin phototype and hair color, as well as family history of melanoma and, to some extent, the number of primary melanoma tumors. The results show that PRS is strongly associated with melanoma risk in the Swedish population and may serve as a valuable tool for understanding genetic susceptibility and improving risk stratification in melanoma prevention and clinical management.

Indexed as

Genetic Predisposition to DiseaseMelanomaMultifactorial InheritanceSkin NeoplasmsCase-Control StudiesCutaneous Malignant MelanomaFemaleGenetic Risk ScoreHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsSweden

Identifiers

PMID42754918
PMCPMC13586051

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.